Abstract:Objective: Major depressive disorder is characterized by reduced reward-related striatal activation and dysfunctional reward learning, putatively reflecting decreased dopaminergic signaling. The goal of this study was to test whether a pharmacological challenge designed to facilitate dopaminergic transmission can enhance striatal responses to reward and improve reward learning in depressed individuals. Method: In a double-blind placebo-controlled design, 46 unmedicated depressed participants and 43 healthy control participants were randomly assigned to receive either placebo or a single low dose (50 mg) of the D2/D3 receptor antagonist amisulpride, which is believed to increase dopamine signaling through presynaptic autoreceptor blockade. To investigate the effects of increased dopaminergic transmission on reward-related striatal function and behavior, a monetary incentive delay task (in conjunction with functional MRI) and a probabilistic reward learning task were administered at absorption peaks of amisulpride. Results: Depressed participants selected previously rewarded stimuli less frequently than did control participants, indicating reduced reward learning, but this effect was not modulated by amisulpride. Relative to depressed participants receiving placebo (and control participants receiving amisulpride), depressed participants receiving amisulpride exhibited increased striatal activation and potentiated corticostriatal functional connectivity between the nucleus accumbens and the midcingulate cortex in response to monetary rewards. Stronger corticostriatal connectivity in response to rewards predicted better reward learning among depressed individuals receiving amisulpride as well as among control participants receiving placebo. Conclusions: Acute enhancement of dopaminergic transmission potentiated reward-related striatal activation and corticostriatal functional connectivity in depressed individuals but had no behavioral effects. Taken together, the results suggest that targeted pharmacological treatments may normalize neural correlates of reward processing in depression; despite such acute effects on neural function, behavioral modification may require more chronic exposure. This is consistent with previous reports that antidepressant effects of amisulpride in depression emerged after sustained administration.

Amisulpride-induced Acute Akathisia in OCD: an Example of Dysfunctional Dopamine–serotonin Interactions?

Impaired Visuospatial Associative Memory and Attention in Obsessive Compulsive Disorder but No Evidence for Differential Dopaminergic Modulation

Evaluation of akathisia in patients receiving selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors

Neuroendocrine and Behavioral Responses to Challenge with the Indirect Serotonin Agonist Dl-Fenfluramine in Adults with Obsessive-Compulsive Disorder

[Molecular Pharmacogenetic Studies of Drug Responses to Obsessive-Compulsive Disorder and Six Functional Genes].

The effects of acute serotonin challenge on executive planning in patients with obsessive–compulsive disorder (OCD), their first-degree relatives, and healthy controls

Amphetamine-Induced OCD-Related Repetitive Behaviors Are Potentiated in Slc1a1-OE Mice

Serotonergic underpinnings of obsessive‐compulsive disorder: A systematic review and meta‐analysis of neuroimaging findings

Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY

Enhanced Dopamine Transporter Density in Psychotropic-Naive Patients with Obsessive-Compulsive Disorder Shown by [123I]β-Cit SPECT

The Role of Anxiety in the Development of Levodopa-Induced Dyskinesias in an Animal Model of Parkinson’s Disease, and the Effect of Chronic Treatment with the Selective Serotonin Reuptake Inhibitor Citalopram

Brain Functional Connectivity in Stimulant Drug Dependence and Obsessive–compulsive Disorder

Dopaminergic Drug Treatment Remediates Exaggerated Cingulate Prediction Error Responses in Obsessive-Compulsive Disorder.

Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence.

The Dopamine D2/D3 Receptor Agonist Quinpirole Increases Checking-Like Behaviour in an Operant Observing Response Task with Uncertain Reinforcement: a Novel Possible Model of OCD.

Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations

Dopaminergic Enhancement of Striatal Response to Reward in Major Depression

Unveiling serotonergic dysfunction of obsessive-compulsive disorder on prefrontal network dynamics: a computational perspective

Limbic cortico-striato-thalamo-cortical functional connectivity in drug-naïve patients of obsessive-compulsive disorder

Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability

Amelioration of obsessive-compulsive disorder by intracellular acidification of cortical neurons with a proton pump inhibitor